Galapagos NV (GLPGF)
OTCMKTS · Delayed Price · Currency is USD
34.00
0.00 (0.00%)
Feb 11, 2026, 4:00 PM EST
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $2.22 billion as of February 12, 2026. Its market cap has increased by 46.08% in one year.
Market Cap
2.22B
Enterprise Value
-1.39B
Revenue
336.64M
Ranking
n/a
PE Ratio
n/a
Stock Price
$34.00
Market Cap Chart
Since March 31, 2014, Galapagos NV's market cap has increased from 656.84M to 2.22B, an increase of 238.06%. That is a compound annual growth rate of 10.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 2.22B | 2.50% |
| Dec 31, 2025 | 2.17B | 19.74% |
| Dec 31, 2024 | 1.81B | -32.85% |
| Dec 29, 2023 | 2.69B | -7.39% |
| Dec 30, 2022 | 2.91B | -20.71% |
| Dec 31, 2021 | 3.67B | -43.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 411.40M |
| CytoDyn | 311.51M |
| Silence Therapeutics | 211.61M |
| HST Global | 139.70M |
| Vaxart | 137.92M |
| BioStem Technologies | 92.40M |
| Nuo Therapeutics | 72.43M |
| VitaSpring Biomedical | 51.78M |